ATE124681T1 - Arzneimittelzusammensetzungen zur behandlung von psoriasis. - Google Patents

Arzneimittelzusammensetzungen zur behandlung von psoriasis.

Info

Publication number
ATE124681T1
ATE124681T1 AT88908544T AT88908544T ATE124681T1 AT E124681 T1 ATE124681 T1 AT E124681T1 AT 88908544 T AT88908544 T AT 88908544T AT 88908544 T AT88908544 T AT 88908544T AT E124681 T1 ATE124681 T1 AT E124681T1
Authority
AT
Austria
Prior art keywords
psoriasis
treatment
medicinal compositions
compositions
medicinal
Prior art date
Application number
AT88908544T
Other languages
English (en)
Inventor
Izhak Blank
Original Assignee
Dexter Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexter Chemical Corp filed Critical Dexter Chemical Corp
Application granted granted Critical
Publication of ATE124681T1 publication Critical patent/ATE124681T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT88908544T 1987-09-04 1988-09-01 Arzneimittelzusammensetzungen zur behandlung von psoriasis. ATE124681T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL83775A IL83775A (en) 1987-09-04 1987-09-04 Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis

Publications (1)

Publication Number Publication Date
ATE124681T1 true ATE124681T1 (de) 1995-07-15

Family

ID=11058151

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88908544T ATE124681T1 (de) 1987-09-04 1988-09-01 Arzneimittelzusammensetzungen zur behandlung von psoriasis.

Country Status (14)

Country Link
EP (1) EP0328634B1 (de)
JP (1) JPH0745451B2 (de)
KR (1) KR890701545A (de)
AT (1) ATE124681T1 (de)
AU (1) AU618759B2 (de)
CA (1) CA1340005C (de)
DE (1) DE3854121T2 (de)
DK (1) DK218189A (de)
FI (1) FI891986A0 (de)
IL (1) IL83775A (de)
IN (1) IN167848B (de)
NO (1) NO891703D0 (de)
WO (1) WO1989001930A1 (de)
ZA (1) ZA886097B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
AU1271592A (en) * 1991-01-18 1992-08-27 Dexter Chemical Corporation Malic acid derivatives and compositions for the treatment of psoriasis
US5856418A (en) * 1996-04-16 1999-01-05 Nippon Shokubai Co., Ltd. Water-soluble monomer, water-soluble polymer and their production process and use
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
WO2002055063A2 (de) 2001-01-12 2002-07-18 Fumapharm Ag Fumarsäureamide
DE10217314A1 (de) * 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
MXPA06002657A (es) 2003-09-09 2006-06-05 Fumapharm Ag Uso de derivados de acido fumarico para el tratamiento de insuficiencia cardiaca y asma.
FI121915B (fi) * 2004-02-06 2011-06-15 Neurofood Ab Oy Koostumus psoriasiksen hoitoon
SI1799196T1 (sl) 2004-10-08 2016-10-28 Forward Pharma A/S Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline
RS63489B1 (sr) 2007-02-08 2022-09-30 Biogen Ma Inc Kompozicije i upotrebe za tretiranje multiple skleroze
US20100158829A1 (en) * 2008-12-24 2010-06-24 Conopco, Inc., D/B/A Unilever Method and Composition for Color Modulation
RU2552951C2 (ru) 2009-01-09 2015-06-10 Форвард Фарма А/С Фармацевтический состав, содержащий один или более эфиров фумаровой кислоты в разлагаемой матрице
DK2521447T3 (en) 2010-01-08 2017-09-18 Catabasis Pharmaceuticals Inc Fatty Acid Fumarates and Their Uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790032A (fr) * 1971-10-27 1973-02-01 Elf Union Procede de fonctionnement de bruleurs a emulsion a deux allures
JPS4852741A (de) * 1971-11-04 1973-07-24
CA982530A (en) * 1972-05-23 1976-01-27 Roger Grenetier Device for storing and packaging materials
DE2703964A1 (de) * 1975-07-08 1978-08-03 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US4362737A (en) * 1981-04-13 1982-12-07 Schaefer Rolf Transdermal carrier materials
DE3444915A1 (de) * 1984-12-08 1986-06-12 Hoechst Ag, 6230 Frankfurt N-maleyl-phenylalaninalkylester, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von n-fumarylphenylalaninalkylestern
JPS6248656A (ja) * 1985-08-28 1987-03-03 Showa Denko Kk Ｎ−フマリル−ｌ−フエニルアラニンメチルエステル及びその製法
US4730048A (en) * 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates

Also Published As

Publication number Publication date
AU618759B2 (en) 1992-01-09
KR890701545A (ko) 1989-12-20
NO891703L (no) 1989-04-25
IL83775A (en) 1991-12-15
CA1340005C (en) 1998-08-18
EP0328634A4 (en) 1991-08-21
JPH02501072A (ja) 1990-04-12
WO1989001930A1 (en) 1989-03-09
IN167848B (de) 1990-12-29
DE3854121T2 (de) 1996-03-21
IL83775A0 (en) 1988-02-29
FI891986A (fi) 1989-04-26
NO891703D0 (no) 1989-04-25
AU2423788A (en) 1989-03-31
DK218189D0 (da) 1989-05-03
ZA886097B (en) 1989-06-28
DK218189A (da) 1989-07-03
JPH0745451B2 (ja) 1995-05-17
EP0328634B1 (de) 1995-07-05
FI891986A0 (fi) 1989-04-26
EP0328634A1 (de) 1989-08-23
DE3854121D1 (de) 1995-08-10

Similar Documents

Publication Publication Date Title
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE122006000010I1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten
DE69106586T2 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
PT83309A (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
DE3879709D1 (de) Platin-arzneimittel.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE68918449T2 (de) Siliziumverbindungen zur behandlung von knochen.
ATE74004T1 (de) Mischung zur behandlung von hypercholesterolemie.
DE69026991T2 (de) Phospholipide zur Behandlung der multiplen Sklerose
ATE66780T1 (de) Zubereitung zur behandlung von psoriasis.
ATE64683T1 (de) Zusammensetzung zur behandlung von haemorroiden.
ATE95061T1 (de) Schmiermittelzubereitung zur behandlung von rheuma.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties